Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Morgan

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health AdministrationBryan D Badal, Scott Silvey, Lyuba Dragilev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2008
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis CKaren L Lindsay, Chihiro Morishima, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|September 10, 2024
Association of HDV infection and HCC, hepatic decompensation, and all-cause and liver-related death in a national cohortBinu V John, Dustin Bastaich, Mahmoud Manouchehri Amoli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
Medical Care|March 19, 2020
Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative MethodsVera Yakovchenko, Edward J Miech, Matthew J Chinman, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Annals of Internal Medicine|March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin doseStephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Journal of Hepatology|July 16, 2008
DNA polymorphisms and response to treatment in patients with chronic hepatitis C: results from the HALT-C trialTimothy R Morgan, Richard W Lambrecht, Herbert L Bonkovsky, et al.
Hepatology (Baltimore, Md.)|August 13, 2008
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: randomized study of higher doses of peginterferon alpha-2a and ribavirinMichael W Fried, Donald M Jensen, Maribel Rodriguez-Torres, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health AdministrationBryan D Badal, Scott Silvey, Lyuba Dragilev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2008
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis CKaren L Lindsay, Chihiro Morishima, Elizabeth C Wright, et al.
Hepatology (Baltimore, Md.)|September 10, 2024
Association of HDV infection and HCC, hepatic decompensation, and all-cause and liver-related death in a national cohortBinu V John, Dustin Bastaich, Mahmoud Manouchehri Amoli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trialLeonard B Seeff, Gregory T Everson, Timothy R Morgan, et al.
Gastroenterology|October 27, 2009
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinomaAnna S Lok, Richard K Sterling, James E Everhart, et al.
The American Journal of Gastroenterology|June 13, 2012
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis CChihiro Morishima, Mitchell L Shiffman, Jules L Dienstag, et al.
Medical Care|March 19, 2020
Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative MethodsVera Yakovchenko, Edward J Miech, Matthew J Chinman, et al.
Pageof 18